Heart Failure

View the latest content related to this topic

News Daily News

Nearly 150 Million US Adults Eligible for CKM Syndrome Meds

Observational data point to the scope of opportunity that lies in GLP-1 drugs, SGLT2 inhibitors, and nonsteroidal MRAs.

Caitlin E. Cox

February 02, 2026

Slides

See all

Presentation Cardiovascular Interventions 2025

Transcatheter Mitral Valve-in-Valve, Ring, and MAC: Tips, Tricks, and Pitfalls

Presenter: Curtiss T. Stinis

November 13, 2025

Presentation Cardiovascular Interventions 2025

Transcatheter Tricuspid Repair and Replacement: Which Therapy and When?

Presenter: Matthew J. Price

November 13, 2025

Presentation ESC 2025

DAPA ACT HF – TIMI 68: Dapagliflozin in Patients Hospitalized for Heart Failure

Presenter: David D. Berg

August 30, 2025

Presentation ESC 2025

Mavacamten in Symptomatic Nonobstructive Cardiomyopathy: Primary results of the ODYSSEY-HCM Trial

Presenter: Milind Y Desai

August 30, 2025

Presentation ESC 2025

Vericiguat in ambulatory patients with chronic heart failure with reduced ejection fraction: Results of the VICTOR trial

Presenter: Faiez Zannad

August 30, 2025

News

See all

News Daily News

GLP-1s Provide Benefit in HF Patients: SOUL Subanalysis

By L.A. McKeown

February 06, 2026

News Daily News

Nearly 150 Million US Adults Eligible for CKM Syndrome Meds

By Caitlin E. Cox

February 02, 2026

News Daily News

Even With Optimized GDMT, HFrEF Prognosis Remains Dire

By Michael O'Riordan

January 30, 2026

News Daily News

Cardioprotective Flush, Without Reanimation, Safe and Effective in DCD Transplant

By Michael O'Riordan

January 28, 2026

News Daily News

Telemedicine May Adversely Impact Care Quality for HF Patients

By Caitlin E. Cox

January 26, 2026

ISC 2026

February 4

February 06, 2026

STS 2026

January 29

February 01, 2026

Cardiovascular Interventions 2025

November 11

November 14, 2025

Videos on This Topic

See all

Video Interview

Advertisement

Heart Failure

Nearly 150 Million US Adults Eligible for CKM Syndrome Meds

Slides

Transcatheter Mitral Valve-in-Valve, Ring, and MAC: Tips, Tricks, and Pitfalls

Transcatheter Tricuspid Repair and Replacement: Which Therapy and When?

DAPA ACT HF – TIMI 68: Dapagliflozin in Patients Hospitalized for Heart Failure

Mavacamten in Symptomatic Nonobstructive Cardiomyopathy: Primary results of the ODYSSEY-HCM Trial

Vericiguat in ambulatory patients with chronic heart failure with reduced ejection fraction: Results of the VICTOR trial

News

GLP-1s Provide Benefit in HF Patients: SOUL Subanalysis

Nearly 150 Million US Adults Eligible for CKM Syndrome Meds

Even With Optimized GDMT, HFrEF Prognosis Remains Dire

Cardioprotective Flush, Without Reanimation, Safe and Effective in DCD Transplant

Telemedicine May Adversely Impact Care Quality for HF Patients

More on This Topic

Conference Coverage

ISC 2026

STS 2026

Cardiovascular Interventions 2025

Videos on This Topic

Beyond the Data: DAPA ACT HF – TIMI 68

Advertisement

Heart Failure

Slides

News

More on This Topic

Conference Coverage

Videos on This Topic

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content